- Trials with a EudraCT protocol (356)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (35)
356 result(s) found for: Liver transplant.
Displaying page 1 of 18.
EudraCT Number: 2007-001361-15 | Sponsor Protocol Number: CAEB071B2101 | Start Date*: 2008-01-28 | |||||||||||
Sponsor Name:NOVARTIS FARMA | |||||||||||||
Full Title: An open-label, two-period, multi-center, single dose study to assess the pharmacokinetics of AEB071 in de novo liver transplant patients | |||||||||||||
Medical condition: liver transplant | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-002856-34 | Sponsor Protocol Number: LTx18-01 | Start Date*: 2019-03-01 | |||||||||||
Sponsor Name:Foundation for Liver research | |||||||||||||
Full Title: Modifying tacrolimus related toxicity after liver transplantation. A randomized controlled trial comparing Envarsus® and Advagraf® in de novo liver transplant recipients. | |||||||||||||
Medical condition: liver transplantation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-021333-31 | Sponsor Protocol Number: TOP2010-LMU | Start Date*: 2011-08-23 | |||||||||||
Sponsor Name:Klinikum der Universität München | |||||||||||||
Full Title: Reduktion des Ischämie-Reperfusionsschadens durch ex-vivo Tacrolimus-Perfusion marginaler Organe vor Lebertransplantation (Tacrolimus-Organ-Perfusion TOP-Studie) | |||||||||||||
Medical condition: Chonical terminal liver insufficiency | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-004557-14 | Sponsor Protocol Number: NA | Start Date*: 2015-02-09 | |||||||||||
Sponsor Name:King's College London [...] | |||||||||||||
Full Title: Prospective randomised marker-based trial to assess the clinical utility and safety of biomarker-guided immunosuppression withdrawal in liver transplantation | |||||||||||||
Medical condition: Immunosuppression withdrawal in liver transplantation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) BE (Completed) ES (Prematurely Ended) DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-002231-32 | Sponsor Protocol Number: PMR-EC-1106 | Start Date*: 2009-03-04 | |||||||||||
Sponsor Name:Astellas Pharma Europe Ltd. | |||||||||||||
Full Title: A MULTICENTER, THREE ARM, RANDOMIZED, OPEN LABEL CLINICAL STUDY TO COMPARE RENAL FUNCTION IN LIVER TRANSPLANT RECIPIENTS RECEIVING AN IMMUNOSUPPRESSIVE REGIMEN OF ADVAGRAF® (IMMEDIATELY OR DELAYED... | |||||||||||||
Medical condition: RENAL FUNCTION IN LIVER TRANSPLANT RECIPIENTS RECEIVING AN IMMUNOSUPPRESSIVE REGIMEN OF ADVAGRAF® (IMMEDIATELY OR DELAYED POST-TRANSPLANT) AND MMF WITH OR WITHOUT SIMULECT | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) AT (Completed) HU (Completed) BE (Completed) CZ (Completed) IE (Completed) DE (Completed) FR (Completed) ES (Completed) GB (Completed) IT (Completed) SE (Completed) DK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-002510-13 | Sponsor Protocol Number: TROMBOFIBtrial | Start Date*: 2018-09-28 | |||||||||||
Sponsor Name:Antoni Sabaté Pes (Servicio de Anestesiología y Reanimación) del Hospital Universitari de Bellvitge | |||||||||||||
Full Title: Impact of two thrombelastography-guided strategies of fibrinogen correction on blood product requirements in liver transplantation: a multicenter, randomized trial. TROMBOFIB trial | |||||||||||||
Medical condition: Liver transplantation is a special risk situation for acute and severe bleeding determined by the complexity of the surgical procedure and by the alteration of haemostasis and coagulation factors, ... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-012258-19 | Sponsor Protocol Number: F506-CL-0403 | Start Date*: 2011-03-09 | |||||||||||||||||||||
Sponsor Name:Astellas Pharma Europe Ltd. | |||||||||||||||||||||||
Full Title: A Multicentre, Open-label, Pharmacokinetic Study of Modigraf® (Tacrolimus granules) in de novo Paediatric Allograft Recipients.Estudio Abierto, Multicéntrico, Farmacocinético de Modigraf® (Tacróli... | |||||||||||||||||||||||
Medical condition: De novo allograft transplantation (liver, heart, kidney) in paediatric patients. Pacientes pediátricos que reciben un trasplante de aloinjerto de novo ( hígado, corazón y riñón) | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: ES (Completed) GB (Completed) DE (Completed) BE (Completed) FR (Ongoing) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-004268-38 | Sponsor Protocol Number: Transplant_ABT-1 | Start Date*: 2014-10-27 | ||||||||||||||||
Sponsor Name:Semmelweis Egyetem Transzplantációs és Sebészeti Klinika | ||||||||||||||||||
Full Title: Individual Patient Access to AbbVie ABT-450/ritopnavir/ABT-267 and ABT-333 Coadministeres with ribavirin (RBV) in Adult Liver Transplant Recipient with Genotype 1 Hepatitis C Virus Infection | ||||||||||||||||||
Medical condition: | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: HU (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-015890-11 | Sponsor Protocol Number: AGO/2009/007 | Start Date*: 2009-11-03 | |||||||||||
Sponsor Name:University Hospital Ghent | |||||||||||||
Full Title: Conditioning with volatile anesthetics in liver transplantation | |||||||||||||
Medical condition: Liver transplantation | |||||||||||||
|
|||||||||||||
Population Age: | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-000936-28 | Sponsor Protocol Number: PMR-EC-1105 | Start Date*: 2006-09-14 | |||||||||||
Sponsor Name:Astellas Pharma Europe Limited | |||||||||||||
Full Title: A MULTICENTER, OPEN, SINGLE SEQUENCE CROSSOVER STUDY TO ASSESS THE SAFETY AND EFFICACY OF A TACROLIMUS MODIFIED RELEASE, FK506E (MR4), BASED IMMUNOSUPPRESSIVE REGIMEN IN STABLE LIVER TRANSPLANT PAT... | |||||||||||||
Medical condition: Stable, adult liver transplant recipients (≥ 12 months post transplant) who are currently treated with Prograf. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) IE (Completed) ES (Completed) FR (Completed) CZ (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-002802-30 | Sponsor Protocol Number: GS-US-337-0124 | Start Date*: 2014-03-12 | |||||||||||
Sponsor Name:Gilead Sciences, Inc. | |||||||||||||
Full Title: A Phase 2, Multicenter, Open-Label Study to Investigate the Safety and Efficacy of Sofosbuvir/Ledipasvir Fixed-Dose Combination + Ribavirin Administered in Subjects Infected with Chronic HCV who ha... | |||||||||||||
Medical condition: Chronic Genotype 1 and Genotype 4 Hepatitis C Virus Infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) GB (Completed) DE (Completed) IT (Completed) AT (Completed) NL (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-004325-91 | Sponsor Protocol Number: CRAD001HIT34 | Start Date*: 2014-01-25 | |||||||||||
Sponsor Name:NOVARTIS FARMA S.p.A | |||||||||||||
Full Title: Multicenter, prospective, open-label, controlled, randomized, parallel groups study to evaluate the renal function of adult liver transplant recipients treated with two everolimus-based immunosuppr... | |||||||||||||
Medical condition: liver transplant | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-001581-20 | Sponsor Protocol Number: IRRB/72/14 | Start Date*: 2018-02-08 | |||||||||||||||||||||
Sponsor Name:ISTITUTO MEDITERRANEO PER I TRAPIANTI E TERAPIE AD ALTA SPECIALIZZAZIONE - ISMETT | |||||||||||||||||||||||
Full Title: THE ADDITION OF SIMVASTATIN ADMINISTRATION TO COLD STORAGE SOLUTION OF EXPLANTED WHOLE LIVER GRAFTS FOR FACING ISCHEMIA/REPERFUSION INJURY IN AN AREA WITH LOW RATE OF DECEASED DONATION. A MONOCENT... | |||||||||||||||||||||||
Medical condition: ISCHEMIC REPERFUSION INJURY AFTER LIVER TRANSPLANTATION: HEPATIC ISCHEMIA AND REPERFUSION INJURY REPRESENTS THE MAIN UNDERLYING MECHANISM FOR GRAFT DYSFUNCTION, AND FAILURE, POST-TRANSPLANTATION. H... | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: IT (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-007177-20 | Sponsor Protocol Number: Sirolimus_Liver_Tolerance | Start Date*: 2009-09-07 | |||||||||||
Sponsor Name:Hospital Clinic Barcelona | |||||||||||||
Full Title: EFECTO DEL SIROLIMUS SOBRE LOS BIOMARCADORES RELACIONADOS CON LA TOLERANCIA EN RECEPTORES DE TRASPLANTE HEPÁTICO ESTABLES | |||||||||||||
Medical condition: Stable liver transplant recipients identified as non-tolerant (i.e. requiring indefinite immunosuppressive therapy) on the basis of peripheral blood transcriptional biomarkers. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-010640-34 | Sponsor Protocol Number: THYTOTRA | Start Date*: 2009-08-13 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA POLICLINICO DI MODENA | |||||||||||||
Full Title: INDUCTION OF DONOR-SPECIFIC TOLERANCE IN PATIENTS WITH LIVER TRANSPLANTATION WITH RECIPIENT PRE-TREATMENT WITH THYMOGLOBULINE AND MINIMAL POST-TRANSPLANT IMMUNOSUPPRESSION. | |||||||||||||
Medical condition: Adult recipients of first liver transplantation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-002105-22 | Sponsor Protocol Number: EVL-VHC-HVH.12 | Start Date*: 2012-08-17 | ||||||||||||||||
Sponsor Name:Dra Itxarone Bilbao. Servicio de cirugía hepatobiliopancreatica y trasplantes. HUVH | ||||||||||||||||||
Full Title: Personal monitoring of liver transplant patients infected with Hepatitis C Virus. Pilot study to compare the evolution of Hepatitis C by receiving immunosuppression with tacrolimus in combination w... | ||||||||||||||||||
Medical condition: Recurrence of hepatitis C post-liver transplantation in patients with hepatitic C. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2008-000627-26 | Sponsor Protocol Number: FK04 | Start Date*: 2008-09-29 | |||||||||||
Sponsor Name:Leiden University Medical Center | |||||||||||||
Full Title: Conversion from cyclosporine to tacrolimus followed by randomized C0 or Bayesian monitoring using the C4 timepoint The effect on kidney function | |||||||||||||
Medical condition: Effect of immunosuppressive medication on renal function following livertransplantation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-005453-13 | Sponsor Protocol Number: EGRADICATE | Start Date*: 2016-08-03 | ||||||||||||||||
Sponsor Name:Fundació clínic per a la Recerca Biomèdica | ||||||||||||||||||
Full Title: PILOT STUDY TO EVALUATE THE EFFICACY AND TOLERABILITY OF GRAZOPREVIR + ELBASVIR FOR 12 OR 16 WEEKS IN LIVER TRANSPLANT RECIPIENTS | ||||||||||||||||||
Medical condition: HCV infection and liver trasplant | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2005-002234-35 | Sponsor Protocol Number: CERL080ADE09 | Start Date*: 2006-10-05 | |||||||||||
Sponsor Name:Novartis Pharma GmbH | |||||||||||||
Full Title: Measurement of Patient Reported Gastrointestinal (GI) and Health-related Quality of Life (HRQL) Outcomes in Liver Transplant Recipients | |||||||||||||
Medical condition: patients who have received a liver transplant treated with mycophenolic acid | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-001872-12 | Sponsor Protocol Number: CL-N-LTX-III/08-ESP/19 | Start Date*: 2021-12-28 | |||||||||||||||||||||
Sponsor Name:Dr. Franz Köhler Chemie GmbH | |||||||||||||||||||||||
Full Title: A Prospective, randomized, single blind, multicenter Phase III study on organ preservation with Custodiol-N solution compared with Custodiol solution in liver transplantation | |||||||||||||||||||||||
Medical condition: Liver transplantation. | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
